NeuroPace (NPCE) Debt to Equity (2020 - 2025)
Historic Debt to Equity for NeuroPace (NPCE) over the last 6 years, with Q3 2025 value amounting to $3.17.
- NeuroPace's Debt to Equity fell 4741.79% to $3.17 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.17, marking a year-over-year decrease of 4741.79%. This contributed to the annual value of $7.43 for FY2024, which is 16939.17% up from last year.
- According to the latest figures from Q3 2025, NeuroPace's Debt to Equity is $3.17, which was down 4741.79% from $3.02 recorded in Q2 2025.
- Over the past 5 years, NeuroPace's Debt to Equity peaked at $7.43 during Q4 2024, and registered a low of -$0.34 during Q1 2021.
- Over the past 5 years, NeuroPace's median Debt to Equity value was $2.46 (recorded in 2025), while the average stood at $2.57.
- In the last 5 years, NeuroPace's Debt to Equity soared by 33478.72% in 2022 and then plummeted by 4949.07% in 2025.
- Over the past 5 years, NeuroPace's Debt to Equity (Quarter) stood at $0.68 in 2021, then skyrocketed by 124.36% to $1.52 in 2022, then soared by 81.24% to $2.76 in 2023, then surged by 169.39% to $7.43 in 2024, then plummeted by 57.29% to $3.17 in 2025.
- Its Debt to Equity was $3.17 in Q3 2025, compared to $3.02 in Q2 2025 and $2.46 in Q1 2025.